• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 3. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 4. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Comprehensive Analysis of (2S)-2-amino-2-(thian-3-yl)ethan-1-ol (CAS No. 2228033-35-8): Structure, Applications, and Research Insights

The compound (2S)-2-amino-2-(thian-3-yl)ethan-1-ol (CAS No. 2228033-35-8) is a chiral amino alcohol derivative with a unique structural framework, combining a thian-3-yl moiety with an ethanolamine backbone. Its stereospecific (2S) configuration makes it a valuable intermediate in asymmetric synthesis and pharmaceutical research. The presence of both amino and hydroxyl functional groups enhances its versatility in drug design, particularly for targeting neurological and metabolic pathways. Researchers have recently explored its potential in modulating G-protein-coupled receptors (GPCRs), a hotspot in modern drug discovery due to their role in diseases like diabetes and Parkinson's.

In the context of green chemistry and sustainable synthesis, (2S)-2-amino-2-(thian-3-yl)ethan-1-ol has garnered attention for its potential as a biodegradable ligand in catalytic systems. A 2023 study highlighted its efficacy in enantioselective hydrogenation, aligning with the industry's shift toward eco-friendly processes. This aligns with frequent search queries like "sustainable chiral catalysts" and "amino alcohols in green synthesis," reflecting growing interest in environmentally benign methodologies. Furthermore, its low toxicity profile (as per preliminary assays) positions it as a safer alternative to traditional auxiliaries.

The compound's thian-3-yl ring system contributes to its lipophilicity, a property critically discussed in forums on blood-brain barrier (BBB) penetration—a key challenge in CNS drug development. Computational models suggest that derivatives of CAS No. 2228033-35-8 could optimize logP values for improved bioavailability, addressing common search terms such as "improving drug solubility" and "CNS drug design." Recent patent filings also indicate its utility in prodrug formulations, leveraging its hydroxyl group for ester-based delivery systems.

From a synthetic perspective, the preparation of (2S)-2-amino-2-(thian-3-yl)ethan-1-ol often involves asymmetric reductive amination or enzymatic resolution, techniques frequently searched by organic chemists. Its crystalline form (melting point 142–144°C) ensures stability during storage, a practical advantage for industrial-scale applications. Analytical data (NMR, HRMS) confirm its high purity (>98%), meeting stringent requirements for GMP-compliant production—a topic trending in pharmaceutical quality control discussions.

Emerging applications include its role in peptide mimetics, where its rigid thian-3-yl scaffold mimics proline-like turns, a strategy explored in anticancer peptide research. This connects to popular queries like "non-standard amino acids in therapeutics" and "peptide backbone modification." Additionally, its metal-chelating ability (via NH₂ and OH groups) opens doors in diagnostic imaging, particularly for gallium-68 radiopharmaceuticals—a field with exponential growth in PubMed citations since 2020.

In conclusion, (2S)-2-amino-2-(thian-3-yl)ethan-1-ol (CAS No. 2228033-35-8) represents a multifaceted building block bridging medicinal chemistry, catalysis, and material science. Its alignment with trending topics—sustainability, CNS drugs, and precision medicine—ensures continued relevance in both academic and industrial spheres. Future studies may explore its polymeric derivatives for drug-eluting stents or CO₂ capture materials, further expanding its impact.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)